Transient folate deprivation in combination with small-molecule compounds facilitates the generation of somatic cell-derived pluripotent stem cells in mice

Abstract

Induced pluripotent stem cells (iPSCs) can be propagated indefinitely, while maintaining the capacity to differentiate into all cell types in the body except for the extra-embryonic tissues. This iPSC technology not only represents a new way to use individual-specific stem cells for regenerative medicine but also constitutes a novel method to obtain large numbers of disease-specific cells for biomedical research. However, the low efficiency of reprogramming and genomic integration of oncogenes and viral vectors limit the potential application of iPSCs. Chemical-induced reprogramming offers a novel approach to generating iPSCs. In this study, a new combination of small-molecule compounds (SMs) (sodium butyrate, A-83-01, CHIR99021, Y-27632) under conditions of transient folate deprivation was used to generate iPSC. It was found that transient folate deprivation combined with SMs was sufficient to permit reprogramming from mouse embryonic fibroblasts (MEFs) in the presence of transcription factors, Oct4 and Klf4, within 25 days, replacing Sox2 and c-Myc, and accelerated the generation of mouse iPSCs. The resulting cell lines resembled mouse embryonic stem (ES) cells with respect to proliferation rate, morphology, pluripotency-associated markers and gene expressions. Deprivation of folic acid, combined with treating MEFs with SMs, can improve the inducing efficiency of iPSCs and reduce their carcinogenicity and the use of exogenous reprogramming factors.

Keywords

folic acid deprivation / small-molecule compounds / induced pluripotent stem cells

References

[1] TakahashiK, YamanakaS. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4): 663-676

[2] MajadK, KarthikeyanN, HongfangL, et al.. Delivery of reprogramming factors into fibroblasts for generation of non-genetic induced pluripotent stem cells using a cationic bolaamphiphile as a non-viral vector. Biomaterials, 2013, 34(21): 5336-5343

[3] ParkIH, AroraN, HuoH, et al.. Disease-specific induced pluripotent stem cells. Cell, 2008, 134(5): 877-886

[4] LinSY, LeeWR, SuYF, et al.. Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor. Angiogenesis, 2012, 15(4): 671-683

[5] HsuSP, LeeWS. Progesterone receptor activation of extranuclear signaling pathways in regulating p53 expression in vascular endothelial cells. Mol Endocrinol, 2011, 25(3): 421-432

[6] HongH, TakahashiK, IchisakaT, et al.. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature, 2009, 460(7259): 1132-1135

[7] KawamuraT, SuzukiJ, WangYV, et al.. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature, 2009, 460(7259): 1140-1144

[8] LiH, ColladoM, VillasanteA, et al.. The Ink/Arf locus is a barrier for iPS cell reprogramming. Nature, 2009, 460(7259): 1136-1139

[9] MarionRM, StratiK, LiH, et al.. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature, 2009, 460(7259): 1149-1153

[10] UtikalJ, PoloJM, StadtfeldM, et al.. Immortalization eliminates a roadblock during celluar reprogramming into iPS cells. Nature, 2009, 460(7259): 1145-1148

[11] YanQY, QiuZD, HuWT, et al.. An inducing system for differentiation of folate-deficient mouse embryo fibroblasts to pluripotent stem cells. Acta Med Univ Sci Technol Huazhong (Chinese), 2013, 42(2): 192-194

[12] XuY, WeiX, WangM, et al.. Proliferation rate of somatic cells affects reprogramming efficiency. J Biol Chem, 2013, 288(14): 9767-9778

[13] Martinez-FernandezA, NelsonTJ, TerzicA, et al.. Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells. J Cardiovasc TransI Res, 2011, 4(2): 131-137

[14] ZhangY, LiWL, LaurentT, et al.. Small molecules, big roles—the chemical manipulation of stem cell fate and somatic cell reprogramming. J Cell Sci, 2012, 125(Pt23): 5609-5620

[15] ZhangR, ZhangLH, XieX, et al.. iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery. Acta Pharmacologica Sinica, 2013, 34(6): 765-776

[16] HuangfuD, MaehrR, GuoW, et al.. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol, 2008, 26(7): 795-797

[17] MaliP, ChouBK, YenJ, et al.. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells, 2010, 28(4): 713-720

[18] LiangG, TaranovaO, XiaK, et al.. Butyrate promotes induced pluripotent stem cell generation. J Biol Chem, 2010, 285(33): 25516-25521

[19] ZhangZ, GaoY, GordonA, et al.. Efficient generation of fully reprogrammed human iPS cells via polycistronic retroviral vector and a new cocktail of chemical compounds. PLoS One, 2011, 6(10): e26592

[20] LiR, LiangJ, NiS, et al.. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell, 2010, 7(1): 51-63

[21] LiW, WeiW, ZhuS, et al.. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell, 2009, 4(1): 16-19

[22] LiW, ZhouH, AbujarourR, et al.. Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells, 2009, 27(12): 2992-3000

[23] ChoiYJ, LinCP, HoJJ, et al.. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol, 2011, 13(11): 1353-1360

[24] YeD, WangG, LiuY, et al.. MiR-138 promotes induced pluripotent stem cell generation through the regulation of the P53 Signaling. Stem Cells, 2012, 30(8): 1645-1654